Individualized dual antiplatelet therapy based on platelet function testing in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials

Individualized dual antiplatelet therapy based on platelet function testing in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials

Abstract Background High on-treatment platelet reactivity (HPR) represents a strong risk factor for thrombotic events after PCI. We aim to evaluate the efficacy and safety of individualizing intensified dual antiplatelet therapy (DAPT) in PCI-treated patients with HPR based on platelet function test...

Full description

Bibliographic Details
Main Authors: Yijiang Zhou, Yanwei Wang, Yutao Wu, Chaoyang Huang, Hui Yan, Weiguo Zhu, Weiwei Xu, Li Zhang, Jianhua Zhu
Format: Article
Language:English
Published: BMC 2017-06-01
Series:BMC Cardiovascular Disorders
Subjects:
Clopidogrel
Dual antiplatelet therapy
Percutaneous coronary intervention
High on-treatment atelet reactivity
Online Access:http://link.springer.com/article/10.1186/s12872-017-0582-6

Internet

http://link.springer.com/article/10.1186/s12872-017-0582-6

Similar Items